Date	Period	Revenue/Estimate	Earnings Call
Feb 5, 2025	2025/Q3	34.147B / --	--
Jul 31, 2024	2025/Q1	28.419B / --	--
Feb 6, 2024	2024/Q3	32.330B / --	--
Aug 2, 2023	2024/Q1	27.854B / --	--
Feb 6, 2023	2023/Q3	31.614B / --	--

DatePeriodRevenue/EstimateEarnings Call

Feb 5, 20252025/Q334.147B / ----

Jul 31, 20242025/Q128.419B / ----

Feb 6, 20242024/Q332.330B / ----

Aug 2, 20232024/Q127.854B / ----

Feb 6, 20232023/Q331.614B / ----

Unlock Free Earnings Estimates

Open Account

Kyorin Pharmaceutical: Supplementary financial results for the fiscal year ending March 2025

May 12 02:30 ET

Kyorin Pharmaceutical: Summary of financial results for the fiscal year ending March 31, 2025 [Japanese GAAP] (consolidated)

May 12 02:30 ET

Kyorin Pharmaceutical: Notice regarding revisions to year-end dividend forecasts (special dividends)

May 12 02:30 ET

Kyorin Pharmaceutical: Notice regarding revisions (upward revisions) to full-year earnings forecasts

Apr 22 23:30 ET

4569 Kyorin Pharmaceutical

Kyorin Pharmaceutical Key Stats